
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Vaccine vectors based on Adenovirus 19a/64 exhibit broad cellular tropism and potently restimulate HCMV-specific T cell responses ex vivo
Richard Kiener, M. Fleischmann, Christiane Schwegler, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 11
Richard Kiener, M. Fleischmann, Christiane Schwegler, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 11
Showing 11 citing articles:
Transgene expression knock-down in recombinant Modified Vaccinia virus Ankara vectors improves genetic stability and sustained transgene maintenance across multiple passages
Patrick Neckermann, Madlen Mohr, Martina Billmeier, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Patrick Neckermann, Madlen Mohr, Martina Billmeier, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Efficacy and Synergy with Cisplatin of an Adenovirus Vectored Therapeutic E1E2E6E7 Vaccine against HPV Genome–Positive C3 Cancers in Mice
Ditte Rahbæk Boilesen, Patrick Neckermann, Torsten Willert, et al.
Cancer Immunology Research (2022) Vol. 11, Iss. 2, pp. 261-275
Open Access | Times Cited: 10
Ditte Rahbæk Boilesen, Patrick Neckermann, Torsten Willert, et al.
Cancer Immunology Research (2022) Vol. 11, Iss. 2, pp. 261-275
Open Access | Times Cited: 10
Differential upregulation of host cell protein kinases by the replication of α-, β- and γ-herpesviruses provides a signature of virus-specific signalling
Manfred Marschall, Hanife Strojan, Richard Kiener, et al.
Journal of General Virology (2020) Vol. 101, Iss. 3, pp. 284-289
Open Access | Times Cited: 7
Manfred Marschall, Hanife Strojan, Richard Kiener, et al.
Journal of General Virology (2020) Vol. 101, Iss. 3, pp. 284-289
Open Access | Times Cited: 7
Design and Immunological Validation of Macaca fascicularis Papillomavirus Type 3 Based Vaccine Candidates in Outbred Mice: Basis for Future Testing of a Therapeutic Papillomavirus Vaccine in NHPs
Patrick Neckermann, Ditte Rahbæk Boilesen, Torsten Willert, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 5
Patrick Neckermann, Ditte Rahbæk Boilesen, Torsten Willert, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 5
Development and characterization of HCMV recombinant subunit vaccines based on T-cell epitopes
Jun Li, Xu Li, Fengjun Liu, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126454-126454
Closed Access
Jun Li, Xu Li, Fengjun Liu, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126454-126454
Closed Access
Evaluation of adenoviral vector Ad19a encoding RSV-F as novel vaccine against respiratory syncytial virus
Jana Fuchs, Julian Hübner, Anna Schmidt, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access
Jana Fuchs, Julian Hübner, Anna Schmidt, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access
CD46 Is a Protein Receptor for Human Adenovirus Type 64
Eugene Wu, Alexander Robertson, Haiqing Zhu, et al.
Viruses (2024) Vol. 16, Iss. 12, pp. 1827-1827
Open Access
Eugene Wu, Alexander Robertson, Haiqing Zhu, et al.
Viruses (2024) Vol. 16, Iss. 12, pp. 1827-1827
Open Access
Efficient Delivery of Human Cytomegalovirus T Cell Antigens by Attenuated Sendai Virus Vectors
Richard Kiener, M. Fleischmann, Marian Wiegand, et al.
Journal of Virology (2018) Vol. 92, Iss. 15
Open Access | Times Cited: 3
Richard Kiener, M. Fleischmann, Marian Wiegand, et al.
Journal of Virology (2018) Vol. 92, Iss. 15
Open Access | Times Cited: 3
Preferential Expansion of HPV16 E1-Specific T Cells from Healthy Donors’ PBMCs after Ex Vivo Immunization with an E1E2E6E7 Fusion Antigen
Joana Daradoumis, Mikkel Dons Müller, Patrick Neckermann, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5863-5863
Open Access | Times Cited: 1
Joana Daradoumis, Mikkel Dons Müller, Patrick Neckermann, et al.
Cancers (2023) Vol. 15, Iss. 24, pp. 5863-5863
Open Access | Times Cited: 1
In vitro immune evaluation of adenoviral vector-based platform for infectious diseases
Joanna Baran, Łukasz Kuryk, Teresa Szczepińska, et al.
BioTechnologia (2023) Vol. 104, Iss. 4, pp. 403-419
Open Access | Times Cited: 1
Joanna Baran, Łukasz Kuryk, Teresa Szczepińska, et al.
BioTechnologia (2023) Vol. 104, Iss. 4, pp. 403-419
Open Access | Times Cited: 1
Sequence and vector shapes vaccine induced antibody effector functions in HIV vaccine trials
Stephanie Fischinger, Deniz Cizmeci, Davy Deng, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 11, pp. e1010016-e1010016
Open Access | Times Cited: 2
Stephanie Fischinger, Deniz Cizmeci, Davy Deng, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 11, pp. e1010016-e1010016
Open Access | Times Cited: 2